Publikationen in Zusammenarbeit mit Forschern von Karolinska Institute (8)

2023

  1. Sevelamer Use and Mortality in People with Chronic Kidney Disease Stages 4 and 5 Not on Dialysis

    Journal of Clinical Medicine, Vol. 12, Núm. 24

2021

  1. Disorders in bone-mineral parameters and the risk of death in persons with chronic kidney disease stages 4 and 5: the PECERA study

    Journal of Nephrology, Vol. 34, Núm. 4, pp. 1189-1199

2019

  1. Serum phosphate optimal timing and range associated with patients survival in haemodialysis: The COSMOS study

    Nephrology Dialysis Transplantation, Vol. 34, Núm. 4, pp. 673-681

2018

  1. Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe

    Kidney International, Vol. 93, Núm. 6, pp. 1432-1441

  2. The effect of high-volume online haemodiafiltration on nutritional status and body composition: The ProtEin Stores prEservaTion (PESET) study

    Nephrology Dialysis Transplantation, Vol. 33, Núm. 7, pp. 1223-1235

2013

  1. COSMOS: The dialysis scenario of CKD-MBD in Europe

    Nephrology Dialysis Transplantation, Vol. 28, Núm. 7, pp. 1922-1935

  2. Influence of body mass index on the association of weight changes with mortality in hemodialysis patients

    Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 10, pp. 1725-1733

  3. Use of phosphate-binding agents is associated with a lower risk of mortality

    Kidney International, Vol. 84, Núm. 5, pp. 998-1008